Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

China Pharmaceutical acquires CSPC-NBP group of Chinese finished drug makers for HK8.6bn

Executive Summary

China Pharmaceutical Group Ltd. (bulk drug production with a focus on antibiotics) will buy several privately held finished drug manufacturing units grouped under a shell company known as Robust Sun Holdings Ltd. by issuing 1.196bn new shares (78.16% of China Pharmaceutical’s capital) at HK1.60, worth HK1.9bn ($251mm). Including the issue of HK6.7bn in convertible bonds, the price is HK8.6bn. The aggregate net assets of the acquired companies are at least HK950mm.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies